Bookmark

Add to MyYahoo RSS

Cardinal Health News

News on Cardinal Health (Ticker: CAH) continually updated from thousands of sources around the net.

Friday Sep 12 | CFO

s on the Move: Week Ending Sept. 12

One of the 25 largest companies in the United States with more than $100 billion in annual revenue, Cardinal Health has promoted 25-year company veteran Michael Kaufmann to the top finance seat, effective Nov. 11. He will replace Jeffrey Henderson, 49, who will be retiring next August. Kaufmann has been CEO of Cardinal's pharmaceutical segment since 2009.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Rubber-Plastics, Manufacturing, Dow Chemical, Chemicals, New York

Thu Sep 11, 2014

Customer Interaction Solutions

Cardinal Health Names Michael Kaufmann As CFO, Succeeding Henderson

Healthcare services company Cardinal Health Inc. said Thursday that it has appointed Michael Kaufmann, as chief financial officer of the company, effective November 11, 2014. He will succeed current CFO Jeffrey Henderson, who has previously announced his planned retirement.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pharmaceuticals

Theflyonthewall.com

Cardinal Health appoints Michael C. Kaufmann as CFO

Cardinal Health appoints Michael C. Kaufmann as CFO Cardinal Health has named Michael C. Kaufmann, 51, CFO effective Nov. 11. This follows the previously announced planned retirement of current CFO Jeffrey W. Henderson, 49. Jon Giacomin, 49, has been named to the role of CEO of the Pharmaceutical segment, currently held by Mike Kaufmann, also effective Nov. 11.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pharmaceuticals

Mon Sep 08, 2014

AmericanBankingNews.com

Cardinal Health Insider Carole S. Watkins Sells 40,794 Shares

Cardinal Health Insider Carole S. Watkins unloaded 40,794 shares of the stock in a transaction dated Friday, September 5th. The shares were sold at an average price of $75.00, for a total transaction of $3,059,550.00.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pharmaceuticals

Fri Sep 05, 2014

AmericanBankingNews.com

Cardinal Health CEO Michael C. Kaufmann Sells 50,216 Shares

Cardinal Health CEO Michael C. Kaufmann unloaded 50,216 shares of the stock on the open market in a transaction dated Thursday, September 4th. The stock was sold at an average price of $74.95, for a total transaction of $3,763,689.20.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry

Thu Sep 04, 2014

AmericanBankingNews.com

Morningstar Issues A Credit Rating to Cardinal Health

Cardinal Health has received an "A" credit rating from analysts at Morningstar . The agency's "A" rating suggests that the company is a low default risk.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Cardinal Health, Incentive Solutions, Allegiance

Fri Aug 29, 2014

Freshnews

Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission

In part four of a blog series that addresses how to leverage a hospital pharmacy as a strategic asset, Mary Baxter, MBA, RPh ., vice president and national practice leader for Cardinal Health's Innovation Delivery Solutions business, discusses how expanding patient access to quality pharmacy care can benefit both hospitals and patients.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Cardinal Health, Incentive Solutions, Allegiance, Dublin, OH

Thu Aug 28, 2014

AmericanBankingNews.com

Cardinal Health CFO Jeffrey William Henderson Sells 26,567 Shares

Cardinal Health CFO Jeffrey William Henderson unloaded 26,567 shares of the stock on the open market in a transaction dated Wednesday, August 27th.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry

Tue Aug 26, 2014

jdsupra.com

Bundled Discounts Subject to Section 1/Clayton 3 Scrutiny In the...

Bundled discount programs have received significant antitrust scrutiny over the past decade, even though these marketing programs may benefit both consumers and competition.

Comment?

Related Topix: Marketing, Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Owens and Minor, Medical Equipment

Mon Aug 25, 2014

AmericanBankingNews.com

Cardinal Health Given Average Rating of "Buy" by Analysts

Cardinal Health has been given a consensus recommendation of "Buy" by the nineteen ratings firms that are currently covering the stock, AR Network reports .

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry

Thu Aug 21, 2014

Seeking Alpha

Without Its Tax Dodge, What's Walgreen Worth?

The company's adjustments to financial guidance issued as part of the no-inversion announcement confirmed that the tax inversion enthusiasm was masking weakness in Walgreen's business.

Comment?

Related Topix: Walgreens, Retail, Rite Aid, Express Scripts, Biotech, Medicine, Pharmaceuticals, Healthcare Industry, McKesson, Household Products

AmericanBankingNews.com

Cardinal Health EVP Mark R. Blake Unloads 4,782 Shares

Cardinal Health EVP Mark R. Blake unloaded 4,782 shares of Cardinal Health stock in a transaction that occurred on Monday, August 18th.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Corporate / Securities Law, Law

Tue Aug 19, 2014

AmericanBankingNews.com

Insider Selling: Jeffrey William Henderson Sells 78,637 Shares of Cardinal Health Stock

Cardinal Health CFO Jeffrey William Henderson sold 78,637 shares of the stock in a transaction that occurred on Monday, August 18th.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pharmaceuticals

AmericanBankingNews.com

Insider Selling: Cardinal Health CEO Sells 6,833 Shares of Stock

Cardinal Health CEO Michael C. Kaufmann sold 6,833 shares of Cardinal Health stock on the open market in a transaction that occurred on Monday, August 18th.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry

AmericanBankingNews.com

Cardinal Health EVP Sells $345,021 in Stock

Cardinal Health EVP Mark R. Blake sold 4,782 shares of the company's stock on the open market in a transaction dated Monday, August 18th.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pharmaceuticals

•••
•••
•••
•••

Woodbridge Jobs

•••
•••
•••
•••